All In Biotech

Drug Trial Radar · NCT03104517

Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

CELLEBRATE: A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Persistent or Recurrent Stress Urinary Incontinence Following Surgical Treatment

Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

96

Planned (sponsor's estimate)

Start

Apr 23, 2019

Primary completion

Jun 11, 2026

Study completion Nov 2026

Sponsor

Lead sponsor
Cook MyoSiteIndustry
Sponsor type
Industry
First posted
Apr 7, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.

Conditions

  • Stress Urinary Incontinence

Interventions

  • AMDC-USR (iltamiocel)Biological

    Autologous Muscle Derived Cells for Urinary Sphincter Repair (generic name: iltamiocel)

  • PlaceboOther

    Placebo control is the vehicle solution used for the study product.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of leaks due to stress incontinence episodes, as recorded in a diaryTime frame: 12 months

Locations

21 sites in 2 countries. Site status is shown where the registry gives one.

  • Del Sol Research Management, LLC

    Tucson, Arizona

  • San Diego Clinical Trials

    La Mesa, California

  • UCLA Women's Health Clinical Research Unit/Department of OBGYN

    Los Angeles, California

  • Stanford Hospital and Clinics

    Stanford, California

  • American Association of Female Pelvic Medicines Research Institute

    Westlake Village, California

  • MedStar Georgetown Hospital Department of Urology

    Washington D.C., District of Columbia

  • University of Kansas Health System

    Kansas City, Kansas

  • Bennett Institute of Urogynecology and Incontinence

    Grand Rapids, Michigan

  • University of New Mexico Women's Care Clinic

    Albuquerque, New Mexico

  • AccuMed Research Associates

    Garden City, New York

  • Northwell Health/The Arthur Smith Institute for Urology

    Lake Success, New York

  • Columbia University Irving Medical Center

    New York, New York

  • Atrium Health

    Charlotte, North Carolina

  • Cleveland Clinic/Glickman Institute-Q10

    Cleveland, Ohio

  • Magee Women's Hospital of UPMC

    Pittsburgh, Pennsylvania

  • Sanford Female Pelvic Medicine and Reconstructive Surgery Clinic

    Sioux Falls, South Dakota

  • Vanderbilt University Medical Center, Dept. of Urologic Surgery

    Nashville, Tennessee

  • Houston Methodist Hospital

    Houston, Texas

  • Cedar Health Research

    Irving, Texas

  • Virginia Mason Medical Center

    Seattle, Washington

  • Derriford Hospital

    Plymouth, Devon, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.